• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

所设计的可生物降解顺铂微球的形态学

Morphology of the designed biodegradable cisplatin microsphere.

作者信息

Natsugoe S, Tokuda K, Shimada M, Kumanohoso T, Baba M, Takao S, Tabata M, Nakamura K, Yoshizawa H, Aikou T

机构信息

First Department of Surgery, Kagoshima University School of Medicine, Japan.

出版信息

Anticancer Res. 1999 Nov-Dec;19(6B):5163-7.

PMID:10697528
Abstract

We observed the morphological changes in microspheres containing cisplatin (CDDP) embedded in poly-d,l,-lactic acid (PLA) and polyethylene glycol acid (CDDP-PPMS). The in vitro release of CDDP from CDDP-PPMS continued for more than four weeks. Scanning electron microscopy revealed that though the particles of CDDP-PPMS were spherical and superficially smooth, small pores with a superficial irregularity appeared six months later. CDDP-PPMS particles were found in the stomata of the omentum after intraperitoneal administration. When CDDP-PPMS was administered after Yoshida sarcoma cells were intraperitoneally transplanted, CDDP-PPMS was observed histologically in the necrotic tissues of the omentum. These experimental results confirmed the release of CDDP from CDDP-PPMS and the histological efficacy of CDDP-PPMS in the omentum against peritoneal metastasis.

摘要

我们观察了聚-d,l-乳酸(PLA)和聚乙醇酸(CDDP-PPMS)包载顺铂(CDDP)的微球的形态变化。CDDP从CDDP-PPMS的体外释放持续了四周以上。扫描电子显微镜显示,尽管CDDP-PPMS颗粒呈球形且表面光滑,但六个月后出现了表面不规则的小孔。腹腔给药后,在大网膜的气孔中发现了CDDP-PPMS颗粒。当在吉田肉瘤细胞腹腔移植后给予CDDP-PPMS时,在组织学上观察到CDDP-PPMS存在于大网膜的坏死组织中。这些实验结果证实了CDDP从CDDP-PPMS中的释放以及CDDP-PPMS在大网膜中对腹膜转移的组织学疗效。

相似文献

1
Morphology of the designed biodegradable cisplatin microsphere.所设计的可生物降解顺铂微球的形态学
Anticancer Res. 1999 Nov-Dec;19(6B):5163-7.
2
Design and testing of a new cisplatin form using a base material by combining poly-D,L-lactic acid and polyethylene glycol acid against peritoneal metastasis.使用聚-D,L-乳酸和聚乙醇酸作为基础材料联合设计并测试一种新型顺铂制剂以对抗腹膜转移。
Int J Cancer. 1998 May 29;76(5):709-12. doi: 10.1002/(sici)1097-0215(19980529)76:5<709::aid-ijc16>3.0.co;2-z.
3
Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.含顺铂微球作为卵巢癌腹腔化疗的实验与临床评估
Anticancer Res. 1998 Jul-Aug;18(4B):2837-42.
4
[Studies on preparation and characteristics of cisplatin chitosan microspheres].[顺铂壳聚糖微球的制备及特性研究]
Yao Xue Xue Bao. 1996;31(4):300-5.
5
Controlled release of cisplatin incorporated into biodegradable poly-d, l-lactic acid.顺铂掺入可生物降解的聚-d,l-乳酸中的控释。
Anticancer Res. 1997 May-Jun;17(3C):1957-60.
6
Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide.通过聚丙交酯-乙交酯包封来降低顺铂的全身暴露和毒性。
Cancer Res. 1992 Dec 1;52(23):6653-6.
7
[Experimental study of cisplatin microspheres incorporated in polylactic acid and polyethylene glycol acid on peritoneal carcinomatosis in rats].聚乳酸与聚乙醇酸包裹顺铂微球对大鼠腹膜癌种植转移影响的实验研究
Gan To Kagaku Ryoho. 1996 Sep;23(11):1516-8.
8
Novel biodegradable polymers as gene carriers.新型可生物降解聚合物作为基因载体。
Macromol Biosci. 2004 Dec 15;4(12):1113-7. doi: 10.1002/mabi.200400125.
9
Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.顺铂聚乳酸-羟基乙酸共聚物微球的肺靶向研究。
Int J Pharm. 2005 Jan 31;289(1-2):63-7. doi: 10.1016/j.ijpharm.2004.10.017. Epub 2004 Dec 19.
10
[A study of the oncolytic effect of a newly designed CDDP system on an experimental animal model with carcinomatous ascites].
Gan To Kagaku Ryoho. 2002 Nov;29(12):2195-8.

引用本文的文献

1
Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer.微粒载体的多功能性:用于治疗腹膜癌的药效学优化载药微粒的研发
AAPS J. 2015 Sep;17(5):1065-79. doi: 10.1208/s12248-015-9785-x. Epub 2015 Jun 19.
2
Intraperitoneal therapy for peritoneal cancer.腹腔内治疗腹膜癌。
Future Oncol. 2010 Oct;6(10):1625-41. doi: 10.2217/fon.10.100.
3
Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel.载体对腹腔内注射紫杉醇的处置及抗肿瘤活性的影响。
Pharm Res. 2007 Sep;24(9):1691-701. doi: 10.1007/s11095-007-9298-0. Epub 2007 Apr 20.